chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nose was so dry; Lot of vertigo; Very dizzy; Felt so weak; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection,Batch/Lot number was not reported), via an unspecified route of administration on 09Jun2021 as DOSE 1, SINGLE for covid-19 immunisation .Medical history and concomitant medications were not reported.The patient experienced lot of vertigo and very dizzy on Jun2021 with outcome of recovered ,felt weak on Jun2021 with outcome of unknown , nose dry on 17Jun2021 with outcome of unknown. Follow-up (18Jun2021):This female patient reported for herself that she felt dizziness for 3 days from a unspecified date after taking 1st dose of Pfizer covid19 vaccine. Caller was unsure if she can take the 2nd dose. Information on the lot/batch number has been requested.
Intense headache within one hour of receiving injection. Not much relief after Tylenol or ibuprofen. Day 2 (and ongoing)  Headache and high blood pressure. Day 5 (and ongoing) Headache, high blood pressure , double vision, brain fog.
tested positive for covid; temp; chills; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid), PYREXIA (temp), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced COVID-19 (tested positive for covid), PYREXIA (temp), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, COVID-19 (tested positive for covid), PYREXIA (temp), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Information has been received from an approximately 19 years old female patient referring to herself. The patient's concurrent conditions, concomitant medication and medical history were nor provided. On 02-JAN-2007, when the patient was 19 years old she was vaccinated with one dose of GARDASIL (0.5 ml, intramuscular, lot # was reported as 1246F, expiration date unspecified). However she never completed the 3 series vaccination. No adverse effect was reported. Additional information has been requested.
The patient had a fever beginning within 6 hours after immunization. Peak measured temp of 103. On 10/23/2009 he passed out while voiding. Was unconscious for 3 or 4 minutes by the parent's estimation. No seizure like activity. Patient alert, oriented and feeling well within short time after the event.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 20-DEC-2008, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, dosage and route of administration) to the patient. On or about 20-DEC-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Right supraclavicular lymphadenopathy that started on 1/21/21. 2 mobile, firm, tender lymph nodes noted on exam.
This spontaneous report as received from a physician via company representative refers to an unspecified "13-14" year old male patient. On an unknown date the patient received the second dose of VARIVAX (Merck) (route, dosage and lot number unknown). First dose was received on an unknown date. It was reported that the patient had "negative titers" for varicella after receiving 2 doses of VARIVAX (Merck) on unspecified dates. Additional information is not expected because there is no permission to contact physician.
Pt suffered rash, cough, runny nose, fever, et pox lesions.
Pt sustained episode of c. diff infection 3 days after receipt of 1st dose of vaccine; resolved w/10-day course of vancomycin, she went for 2nd vaccine and again developed recurrence of CDI 4 days later. Most likely coincidence, though with prior history of CDI and likely chronic colonization query if disruption of immune system homeostasis may have lead to subsequent c. diff infection? cannot find support of this in literature review to date.
This spontaneous case reported by a physician, describes the occurrence of administered expired product (administration of expired vaccine) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 047C21A) for COVID-19 immunization. No medical history reported. On Nov 9, 2021, patient received the third dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Nov 9, 2021, patient administered expired product (administration of expired vaccine). On Nov 9, 2021, administered expired product (administration of expired vaccine) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Sender's comments: This is a spontaneous case of expired product administered for a 45-year-old, female patient with no medical history. No adverse event reported after administration of the booster dose of the Moderna mRNA-1273. The benefit-risk relationship of the Moderna mRNA-1273 not affected by this report. This case linked to MOD-2021-387050 (patient link).
EXTREME FATIGUE, NAUSEOUS, VOMITING, HEADACHE, BRAIN FOG
5/12/99 rash was small (about 1cm) red bumps all over trunk arms & legs;6th day bumps still present & some redness on trunk;
pt exp loss of color w/dec responsiveness to environmental stimuli which occurred approx 5hr p/vax;pt was taken by amb to ER where was noted to have nl VS, but d/t poor color & responsiveness was observed overnoc in hosp
I feel dizzy, foggy, lightheaded, forgetful, easily confused, unable to speak as articulately as I normally do, and unable to solve complex problems. I have felt this way since my first vaccination, and have already received my second. I wouldn't say the second made it worse, but I definitely don't feel better.
HORRIBLE experience!!!  Felt faint the second the shot went into my arm, and for about 20 minutes afterwards.  (I practice meditation, and I can assure you this was NOT a panic attack or based on nervousness).  Felt heat in my neck and ears, and immediate arm pain.  After 30 minutes, drove home, and felt "spacey" the entire ride home.  Ate some breakfast to see if that would help.  Within 3 hours, I was getting a high fever, muscle aches (EVERYTHING hurt...including the tops of my hands...absoltuely miserable!!), fatigue, dizziness.  THE WORST SIDE EFFECT WAS HEART PALPITATIONS.  MY HEART WAS BEATING OUT OF MY CHEST (ELEVATED BETWEEN 90-120 BPM) FOR A STRAIGHT 36-HOURS!!!!!  HOW COULD THIS BE NORMAL?????  I THOUGHT I WAS GOING TO DIE.  I WORK OUT EVERY DAY...SO MY HEART RATE IS NORMALLY MUCH LOWER...SO THIS WAS EXTREME FOR ME.  It took FOUR DAYS for all of my symptoms to subside.  FOUR DAYS!!!!!  This vaccine is NOT safe, despite what you are telling the general public.  I am an extremely healthy person...I eat healthy (no processed foods), do not drink or do drugs, meditate daily...this was an extreme reaction.  Then, about 5 days later, news broke that the CDC was halting distribution of J+J due to blood clots.  For two weeks, I developed severe anxiety, thinking that I would be a blood clot victim.  Next to my breast cancer experience, this was the WORST health experience I've had in my entire lifetime.  I WOULD NEVER GET ANOTHER VACCINE AGAIN!!!
20x16 cm area of erythema and inflammation, warmth at injection site L lateral thigh
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Apr2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 45 years for covid-19 immunisation. The patient's relevant medical history included: "Type 2 narcolepsy" (unspecified if ongoing); "ultra-rapid metabolizer" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Drug Allergy". The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jul2022) Negative; (05Jul2022) Unknown results. Therapeutic measures were taken as a result of suspected covid-19, drug ineffective. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. On unknown dates, the patiens were vaccinated with improperly stored doses of M-M-R-II (dose, route and lot # not reported). No adverse effect was reported. Additional information has been requested.
Chills; sudden onset right arm weakness less than 24 hours after pfizer booster; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the parent.  A 73-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16Mar2022 09:45 (Lot number: FK9895) at the age of 73 years as dose 3 (booster), single for covid-19 immunization. Relevant medical history included: "Htn" (unspecified if ongoing); "DM" (unspecified if ongoing); "BPH" (unspecified if ongoing). Concomitant medication(s) included: TELMISARTAN; AMARYL; METFORMIN; ASPIRINE; TAMSULOSIN. Vaccination history included: Covid-19 vaccine (Primary series of vaccination completed., Manufacturer name unknown.), for COVID-19 immunization. The patient had no known allergies. The patient had no other vaccine in four weeks. The patient was tested for COVID prior and post vaccination. The following information was reported: CHILLS (hospitalization) with onset 17Mar2022 03:00, outcome "recovered with sequelae", described as "Chills"; MUSCULAR WEAKNESS (hospitalization) with onset 17Mar2022 03:00, outcome "recovered with sequelae", described as "sudden onset right arm weakness less than 24 hours after pfizer booster". The patient was hospitalized for chills, muscular weakness (hospitalization duration: 2 day(s)). The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Mar2022) negative. Therapeutic measures were taken as a result of chills, muscular weakness which included Aspirin.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect vaccine BNT162B2 or Comirnaty in triggering the onset of chills and muscular weakness cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
BOOSTRIX GIVEN TO PATIENT. PATIENT HAS PHOBIA TO INJECTION. PTN GOT SYNCOPE BUT DID NOT PASS OUT. PTN FEELS WEAK. PHARMACIST CALLED 911, PARAMEDIC CHECKED BLOOD PRESSURE, IT WAS LOW IN THE 80S AND IN THE 90S AT TIME OF REPORT. PTN REMAINED CONSCIOUS AND ABLE TO ANSWER QUESTION. NO EPINEPHRINE GIVEN TO PATIENT. COURSE OF EVENTS: ABOUT 1 HOUR. FINAL BLOOD PRESSURE 106/53, PULSE 64.
pt has hives-like area around site of Td inject according to pt has had it since approx 1-2 wks post vax; hive-like area is 1 1/2 cm circular very red, raised & top layer of skin worn away;
Patient began having a myasthenia gravis exacerbation after the 1st vaccine. Then after the second vaccine it got a lot worse with fatigue/SOB, and weakness. Patient has not gained anything back.
Menstruation much heavier than normal the first cycle after receiving the vaccine. Usually I can tell when it is coming (cramping) and there were no signs. I went through hygiene products twice as fast the first day. The second cycle after and since things have been back to normal. I did not visit the doctor but did submit a question about the event to the doctor online.
Agitation, ataxia, dizziness, sneezing, flatulence, abdominal pain, weakness.
ED, Discharged , 4/30/2021 - 5/1/2021 (4 hours), Hospital ED, MD, Last attending, Treatment team, Mild intermittent asthma with exacerbation +1 more, Clinical impression Shortness of Breath Asthma, Chief complaint; ED Provider Notes MD (Physician) Emergency Medicine, Expand All Collapse All. ED PROVIDER NOTE; Patient: MRN: CC/HPI, Patient is a 39 yr.old female presenting to the ED with chief complaint of congestion, shortness of breath. 39-year-old female with a history of asthma/COPD with remote history of carcinoid tumor status post right middle lower lobectomy. Patient takes Singulair, otherwise no medications for maintenance of asthma, does have rescue inhaler and breathing treatments available at home. She has been having some congestion and a little bit of shortness of breath over the last couple days.  She is employed here at the hospital, no recent exposures she is aware of. No sore throat or significant nasal congestion.  No loss of sense of taste or smell. No fevers or chills. She states that she did take a breathing treatment last evening and it helped until this morning. She is not noticed any significant wheezing. Cough is mostly nonproductive. Does have some increased mucus and phlegm in her lungs in her throat. Due to her symptoms she just wanted to be checked out.
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE; This spontaneous report received from a pharmacist concerned a 16 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A, expiry: UNKNOWN) dose was not reported, administered on 17-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 17-JAN-2022, the patient experienced product administered to patient of inappropriate age, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Severe chills. Could not move body for one hour. Whole body hurt for hour and a half. Thirst. Finally went back to sleep. Morning had a severe migraine. Took Tylenol and a nap and I felt my fever break.  Had that fever from 4am until 11:30am. Had headache for the rest of the day until 7pm but was not a migraine after the nap and Tylenol. I would never get this vaccine again. I would rather have covid 1000 more times. (I had it in October and no sickness I?ve ever had will ever compare to that two hours of hell.
84 hours after injection, I had a lot of diarrhea, cramping, sweating, chills/uncontrollable shaking. My temperature was 97.1 degrees Fahrenheit. 85 hours after injection, the diarrhea had blood in it and continued with less coming out for 10 hours.
Low grade fever-2 day. Swelling (L) arm down to elbow and pain.
administer expired vaccine to patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patient, after the manufacture date of expiration) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. Total of 102 doses/vials were given for Lot number: 026C21A. The vial did not undergone to any temperature excursions. It was unknown if the vial was initially stored in the refrigerator.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Report content non-significant information
Several minutes after injection patient reported feeling dizzy and then lost consciousness as he was being assisted onto the ground to avoid falling out of the chair. He seemed to unconscious for about 3 minutes. Breathing never stopped.  As he was coming to he vomited the small amount of water he consumed before passing out. Paramedics arrived several minutes after he gained consciousness and cleared him to go home about 20 minutes later.
never got second dose (more than 35 days after first dose); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (never got second dose (more than 35 days after first dose)) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (never got second dose (more than 35 days after first dose)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (never got second dose (more than 35 days after first dose)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medication was reported.
She developed sudden weakness and  dizziness. End up admitted  at hospital. She currently is bedbound and her weakness has worsened.  For 2 weeks she has not been able to void.
Information has been received from a physician concerning a female who in December 2006, was vaccinated with a "normal dose" of zoster vaccine live (Oka/Merck). In December 2006, after vaccination the patient experienced redness, swelling in an approximately 3 inch by 3 inch area around the injection site. This lasted for two weeks before it subsided. Subsequently, the patient recovered on unspecified therapy. Medical attention was not sought. There was no product quality complaint involved. No further information was provided. Additional information has been requested. Follow-up information has been received from a registered nurse.  It was noted that the patient had a history of postherpetic neuralgia, hemifacial spasm, hypothyroidism and Saltmann's nodular dystrophy in November 1990.  She was vaccinated SC in the right upper armwith a first dose of ZOSTAVAX (Merck) (lot # 652966/0623F) on 14-DEC-2006 at 09:35.  Concomitant therapy included ASPIRIN 43 mg daily, SYNTHROID 50 mcg daily, mulitivitamin, folic acid and chondroitin sulfate sodium (+) glucosamine sulfate.  There was no illness at the time of vaccination.  When the patient was in the office on 22-MAR-2007 she mentioned a reaction she had "back in December" to the vaccine.  At that time she stated that she got a 3 inch diameter welt with erythema after shot.  After 2 weeks it went away and the patient recovered.  The patient had no other problems or concerns since.  No further information was provided.  Additional information is not expected.
Achy, exhausted, nausea, diarrhea, headache.  Contracted covid 19 shortly after receiving first dose of vaccine.
Patient c/o raised, itchy red area the size of 1/2 dollar. Vaccine given 7/12/12. Patient called Health Dept at 11:45 on 7/13/12. Told patient to use cool compress and try to see her MD or if starts feeling worse to go to ER. On (R) arm.
Injection site pain Extremely tired, chills, fever, brief sinus pain, body/joint pain Symptoms resolved at 8:00PM the following day (approximately 29 hours after vaccine administered). Stayed home from work the day after the vaccine administered.
4/22/2021 Tested positive for Covid-19 discovered during Universal Swabbing on Specific Unit. Resident was asymptomatic. COVID-19 screening were completed every 4 hours. 5/3/2021 COVID-19 screening revealed runny nose, declining meds and combative. Urine tea colored and foul smelling, Poor PO Intake. 5/4/2021 resident appeared uncomfortable and distressed with increased respiratory rate. Morphine and Ativan given for comfort measures.  5/5/2021 Deceased.
When patient returned today 12-27-10 for her last HEP B vaccine she reports her (R) arm has pain if she presses deep ever since her last HEP B in July 2010 (6 mo. ago).
Hives Raynaud phenomenon - itching, burning, pain and tenderness on hands and specially tip of my fingers
Patient received a Prevnar vaccine on Saturday morning (May 30, 2015).  Her left arm was cleaned with an alcohol swab.  The injection was administered intramuscualrly in the left deltoid.  On 6/5/15 the patient notified the pharmacy that her arm was sore, swollen, red and warm to the touch.  I advised her to call her physician for consultation.
red, itchy, hot area around injection. itchy bumps on fingers and toes. 5/29/21 8pm
Patient came back on 7/27/2015 and said that her both hands are red and welling big.
Immediately after administering flu shot, patient fainted. Patient was sitting in chair and slid off the chair. Patient's father picked up patient right away and patient woke up. Pharmacy staff called 911 to further assess patient. While waiting patient was alert with normal breathing. Once first responders came to the pharmacy, vitals of patient were normal. After second check of vitals father of patient confirmed patient was ok to go home. Patient went home (did not go to the ER/hospital).